Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape
- PMID: 40066169
- PMCID: PMC11891064
- DOI: 10.3389/fmed.2025.1542400
Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape
Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects millions of people worldwide and is characterized by persistent inflammation, pain, and joint destruction. In RA, the dysregulation of the immune system is well documented. However, the genetic basis of the disease is not fully understood, especially when extra-articular organs are involved. Interstitial lung disease (ILD) is a major cause of morbidity and mortality in patients with RA. Notably, RA-ILD shares several risk factors with idiopathic pulmonary fibrosis (IPF), namely male gender, smoking history, usual interstitial pneumonia (UIP) pattern of fibrosis, and association with the MUC5B rs35705950 polymorphism. In addition, other genetic susceptibilities are reported in RA-ILD for some HLA alleles and other less studied polymorphisms. However, the pathobiology of RA-ILD, particularly whether and to what extent genetic and environmental factors interact to determine the disease, remains elusive. In this review, we summarize and critically discuss the most recent literature on the genetics and pathogenesis of RA-ILD. The main clinical aspects of RA-ILD are also discussed.
Keywords: MUC5B; genetics; idiopathic pulmonary fibrosis; interstitial lung disease; rheumatoid arthritis.
Copyright © 2025 Bernardinello, Zen, Castelli, Cocconcelli, Balestro, Borie and Spagnolo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
References
-
- GBD 2021 Rheumatoid Arthritis Collaborators . Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. (2023) 5:e594–610. doi: 10.1016/S2665-9913(23)00211-4 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
